Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic

BackgroundProlongation of action potential duration (APD) is considered a major antiarrhythmic mechanism (class III), but paradoxically, it frequently is also proarrhythmic (torsade de pointes). Methods and ResultsThe cardiac electrophysiological effects of 702 chemicals (class III or HERG channel block) were studied in 1071 rabbit Langendorff-perfused hearts. Temporal instability of APD, triangulation (duration of phase 3 repolarization), reverse use-dependence, and induction of ectopic beats were measured. Instability, triangulation, and reverse use-dependence were found to be important determinants of proarrhythmia. Agents that lengthened the APD by >50 ms, with induction of instability, triangulation, and reverse use-dependence (n=59), induced proarrhythmia (primarily polymorphic ventricular tachycardia); in their absence (n=19), the same prolongation of APD induced no proarrhythmia but significant antiarrhythmia (P <0.001). Shortening of APD, when accompanied by instability and triangulation, was also markedly proarrhythmic (primarily monomorphic ventricular tachycardia). In experiments in which instability and triangulation were present, proarrhythmia declined with prolongation of APD, but this effect was not large enough to become antiarrhythmic. Only with agents without instability did prolongation of APD become antiarrhythmic. For 20 selected compounds, it was shown that instability of APD and triangulation observed in vitro were strong predictors of in vivo proarrhythmia (torsade de pointes). ConclusionsLengthening of APD without instability or triangulation is not proarrhythmic but rather antiarrhythmic.

[1]  L. Hondeghem Computer Aided Development of Antiarrhythmic Agents with Class IIIa Properties , 1994, Journal of cardiovascular electrophysiology.

[2]  J Hartikainen,et al.  Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy. , 1997, Japanese circulation journal.

[3]  J. Brachmann,et al.  Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in Patients with Chronic Atrial Fibrillation or Flutter: A Prospective Study , 1998, Pacing and clinical electrophysiology : PACE.

[4]  C. January,et al.  Triggered activity in the heart: cellular mechanisms of early after-depolarizations. , 1991, European heart journal.

[5]  A. Garfinkel,et al.  Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. , 1999, Circulation.

[6]  L. Carlsson,et al.  Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations. , 1993, Cardiovascular research.

[7]  B. Katzung,et al.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. , 1977, Biochimica et biophysica acta.

[8]  J. Mason,et al.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. , 1984, Circulation research.

[9]  D. Snyders,et al.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.

[10]  P. C. Viswanathan,et al.  Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. , 1999, Circulation.

[11]  E. Carmeliet Use-dependent block and use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes. , 1993, Circulation research.

[12]  CHARLES ANTZELEVITCH,et al.  The M Cell: , 1999, Journal of cardiovascular electrophysiology.

[13]  E. Williams Classification of Antiarrhythmic Actions , 1989 .

[14]  B. Katzung,et al.  Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. , 1984, Annual review of pharmacology and toxicology.

[15]  S. Hohnloser,et al.  Amiodarone-associated Proarrhythmic Effects: A Review with Special Reference to Torsade de Pointes Tachycardia , 1994, Annals of Internal Medicine.

[16]  D. Roden Mechanisms and management of proarrhythmia. , 1998, The American journal of cardiology.

[17]  E. Carmeliet,et al.  Antiarrhythmic drugs and cardiac ion channels: mechanisms of action. , 1998, Progress in biophysics and molecular biology.

[18]  D H Singer,et al.  Amiodarone blocks calcium current in single guinea pig ventricular myocytes. , 1989, The Journal of pharmacology and experimental therapeutics.

[19]  Neil A. Weiss,et al.  Introductory Statistics , 1982 .

[20]  A Garfinkel,et al.  Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study. , 1999, The American journal of physiology.

[21]  M. Zaniboni,et al.  Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. , 2000, American journal of physiology. Heart and circulatory physiology.

[22]  L. Carlsson,et al.  QTU‐Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit: Etiology and Interventions , 1990, Journal of cardiovascular pharmacology.

[23]  B. Katzung,et al.  The effects of quinidine and verapamil on electrically induced automaticity in the ventricular myocardium of guinea pig. , 1976, The Journal of pharmacology and experimental therapeutics.

[24]  H. Calkins,et al.  Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. , 1997, Circulation.

[25]  B. Fermini,et al.  Rapid and slow components of delayed rectifier current in human atrial myocytes. , 1994, Cardiovascular research.

[26]  C F Starmer,et al.  Proarrhythmic Response to Sodium Channel Blockade: Theoretical Model and Numerical Experiments , 1991, Circulation.

[27]  H Calkins,et al.  Beat‐to‐Beat Repolarization Lability Identifies Patients at Risk for Sudden Cardiac Death , 1998, Journal of cardiovascular electrophysiology.

[28]  Y Rudy,et al.  Cellular arrhythmogenic effects of congenital and acquired long-QT syndrome in the heterogeneous myocardium. , 2000, Circulation.

[29]  H Calkins,et al.  Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations. , 2000, Circulation.